Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
about
Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivitySole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1P body-associated protein Mov10 inhibits HIV-1 replication at multiple stagesDifferential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypesHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityThe range of human APOBEC3H sensitivity to lentiviral Vif proteinsA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityCytidine deamination induced HIV-1 drug resistanceThe HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradationHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoEvolutionary conflicts between viruses and restriction factors shape immunityHIV-1 reverse transcriptionSuppression of APOBEC3-mediated restriction of HIV-1 by VifStructural Insights into HIV-1 Vif-APOBEC3F InteractionStructural determinants of HIV-1 Vif susceptibility and DNA binding in APOBEC3FInsight into the HIV-1 Vif SOCS-box-ElonginBC interactionThe SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complexLikely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistanceEndogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2nCharacterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase componentsStructural analysis of viral infectivity factor of HIV type 1 and its interaction with A3G, EloC and EloBThe Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from MonkeysMultiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteinsIdentification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppressionA conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptationInteractions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded VifAPOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants
P2860
Q21144862-DFC1BA29-D2BD-4341-96E1-14A563BF4475Q24317568-1A263C2D-2E7B-4316-9F3F-9843749096A3Q24611223-D6264B14-64C6-4153-A31D-C46BCA37B250Q24612992-0DA1A6ED-87E3-455C-9CBB-49E1C92C90E7Q24619114-F8DE33EE-6523-450D-92E7-AE1B60450EF8Q24647833-F492ADA5-E976-432C-9A93-CB279ED6EA61Q24653931-A466657C-BC64-4E6D-84FC-A1CE72A3958CQ24656551-58635393-3823-412E-A530-8EB9CF600EA8Q24657298-62EEF3DA-F4CC-4870-A562-186B4188E271Q24657375-1517E6B7-EFB6-4912-8533-83C3C5B8B5A7Q26746070-6805EC6D-D110-4154-97A4-2C21D6E90CC9Q26823568-2DF6D89E-1C24-49D2-9126-AEAAE58E49C8Q26851152-3525EED0-C4F5-4205-8061-7AAF15DD86C3Q27022032-EAF14BA7-C331-4D0D-AC1E-0B35200E4122Q27023387-5D93DA47-2566-47A6-AF65-E743DDFEAB03Q27025150-0C1D5B79-90B7-4183-B7BA-D22FB212BCDDQ27321018-FAC93AAA-F05A-46EF-889A-FC8AEEA390B0Q27680506-A5751CCC-837F-4CC5-B487-6881B7F6B449Q27680599-5899D7F3-D8E5-468F-ABF1-14A081DD60A4Q28474177-E4F05F14-7187-4D35-AD11-B13ABDD7CF9DQ28475150-3E59B1B1-CF5E-4215-A520-A0676CA4971BQ28481286-9D1C2144-ACD8-4C94-A9C4-B203B10F2A25Q28482052-A06F6DBE-A5F1-463B-98FA-108868950F2FQ28540150-54B1CFB2-28C2-4A88-9FCA-90D3DF1E1F54Q30379417-D12E1523-241F-4113-BB2A-ECA802E8347FQ30381745-D04918FE-407C-4837-A4D7-48ECEB0FAC15Q33393637-C769EF24-4038-4616-ABCA-3F1BA5AE24C2Q33583855-31EA1937-AF9E-4DB1-BB09-6D085E67E4F8Q33651576-E78E9173-23EF-42B1-A638-68C2855BE954Q33654949-11AB8410-0FE2-4A93-8644-D3A92753B6B4Q33699581-0CD703A3-7FC8-42F5-8656-7B526B29C900Q33815187-B1B9B949-C78C-4107-8931-4576DA39446CQ33826857-DDFD78A1-1477-4FD2-B6F3-8EDDB60DC93DQ33826968-6C5EDD74-D5B7-468A-B26D-355F98E487D6Q33877299-92154B9D-A2FB-43D8-891C-F4CA1D4B7971Q33877364-8A0726B3-B42E-45E9-BBD2-468443168C78Q34039510-A5B6E9FC-5CCE-4105-B6D3-88C0C6DCAA7FQ34039514-8755F0A2-2F15-4683-9540-7413043E7B4EQ34055413-1D6DA571-AD73-475D-9A8F-C3B76D048713Q34059564-279F4834-F5DB-4FFC-9C16-15039DB37BE5
P2860
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identification of two distinct ...... h human APOBEC3G and APOBEC3F.
@ast
Identification of two distinct ...... h human APOBEC3G and APOBEC3F.
@en
type
label
Identification of two distinct ...... h human APOBEC3G and APOBEC3F.
@ast
Identification of two distinct ...... h human APOBEC3G and APOBEC3F.
@en
prefLabel
Identification of two distinct ...... h human APOBEC3G and APOBEC3F.
@ast
Identification of two distinct ...... h human APOBEC3G and APOBEC3F.
@en
P2860
P356
P1433
P1476
Identification of two distinct ...... th human APOBEC3G and APOBEC3F
@en
P2093
Rebecca A Russell
P2860
P304
P356
10.1128/JVI.00395-07
P407
P577
2007-05-23T00:00:00Z